Ki-20227

HCID 9869779
노트반응
부분 구조 검색유사 구조 찾기

기본 정보

CAS
623142-96-1
표준 SMILES
COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1
InChIKey
SHPFDGWALWEPGS-UHFFFAOYSA-N
분자식
C24H24N4O5S
평균 분자량
480.5 g/mol
단동위원소 질량
480.14674105

이름 및 식별자

우선 이름
Ki-20227
IUPAC
1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2-methoxyphenyl]-3-[1-(1,3-thiazol-2-yl)ethyl]urea
영어명
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea
분자식
C24H24N4O5S
분자량
480.54

이름 및 동의어

Ki20227623142-96-1Ki-20227Ki 20227T4W68CAT3P1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2-methoxyphenyl]-3-[1-(1,3-thiazol-2-yl)ethyl]ureaDTXSID804321081-(4-(6,7-Dimethoxyquinolin-4-yl)oxy-2-methoxyphenyl)-3-(1-(1,3-thiazol-2-yl)ethyl)urea1-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-2-methoxyphenyl}-3-[1-(1,3-thiazol-2-yl)ethyl]urea1-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-2-methoxyphenyl)-3-(1-(1,3-thiazol-2-yl)ethyl)ureaRefChem:151217DTXCID20837658
이름 더 보기
CS-1094Ki20227 ，S7688Ki20227, 10 mM in DMSOUrea, N-[4-[(6,7-diMethoxy-4-quinolinyl)oxy]-2-Methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]-
KI-20227, (A+-)-1-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-2-methoxyphenyl)-3-(1-(thiazol-2-yl)ethyl)ureaN-[4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]-2-METHOXYPHENYL]-N'-[1-(2-THIAZOLYL)ETHYL]UREACHEMBL1908396KI-20227, (+/-)-N-(4-((6,7-Dimethoxy-4-quinolinyl)oxy)-2-methoxyphenyl)-N'-(1-(2-thiazolyl)ethyl)ureaUrea, N-(4-((6,7-dimethoxy-4-quinolinyl)oxy)-2-methoxyphenyl)-N'-(1-(2-thiazolyl)ethyl)-C24H24N4O5S

데이터베이스 식별자

CAS
623142-96-1
PubChem CID
9869779
DTXSID
DTXSID80432108
ChEMBL
CHEMBL1908396
UNII
T4W68CAT3P
Nikkaji
J2.851.477H

물성

구조 계산 물성

XLogP
3.6
극성 표면적
132 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
8
회전 가능 결합 수
8
무거운 원자 수
34

물리화학적 성질

끓는 점
621.8 · 621.8±55.0 °C(Predicted)
밀도
1.327 · 1.327
저장 조건
-20 °C · Sealed in dry,Store in freezer, under -20°C
용해도
48.1 mg/mL · ≥48.1 mg/mL in DMSO; insoluble in H2O; ≥8.6 mg/mL in EtOH with gentle warming and ultrasonic
물리적 상태
갈색 가루.
산도 계수 (pKa)
12.03 · 12.03±0.46(Predicted)

화학 및 산업

응용 분야 · 2건

개요Ki20227 is an inhibitor of macrophage colony stimulating factor 1 (CSF1) receptor tyrosine kinase (c-Fms; IC50 = 2 nM). It inhibits CSF1-dependent c-Fms phosphorylation in a dose-dependent manner in RAW264.7 cells and reduces CSF1-dependent growth of M-NFS-60 cells (IC50 = 14 nM). Ki20227 suppresses development of TRAP-positive osteoclast-like cells from murine bone marrow (IC50 = 40 nM) and decreases the number and area of osteolytic lesions on femurs and tibiae in a murine A375 subcutaneous xenograft model. Ki20227 also reduces TNF-α infiltration and osteolytic bone destruction in a collagen-induced arthritis (CIA) mouse model.

용도Ki 20227 is a c-fms tyrosine kinase inhibitor, which suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.

공급사80 곳

苏州道澜生物医药科技有限公司15952404857 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
武汉灵灵九生物科技有限公司15623309010
湖北科乐精细化工有限公司027-59101668 19945030958 · [email protected]

관련 반응

3건
반응 기록 만들기

화합물 노트

불러오는 중…